Axon Enterprise (NASDAQ:AXON) Given New $700.00 Price Target at The Goldman Sachs Group

Axon Enterprise (NASDAQ:AXON – Get Free Report) had its price objective raised by equities researchers at The Goldman Sachs Group from $500.00 to $700.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. The Goldman Sachs Group’s price target suggests a potential upside of 15.74% […]

Leave a Reply

Your email address will not be published.

Previous post Blue Trust Inc. Boosts Holdings in Philip Morris International Inc. (NYSE:PM)
Next post iCAD, Inc. Pre-Announces Estimated Q4 2024 Revenue